The Value of Magnetic Resonance Imaging of the Optic Nerve for the Diagnosis of Multiple Sclerosis in Patients with Optic Neuritis

Overview

Journal J Neurol

Date 2025 Jan 15

PMID 39812901

Authors

Gorm Pihl-Jensen

Jette Lautrup Frederiksen

Affiliations

Soon will be listed here.

Abstract

Background: Although optic neuritis (ON) is common in multiple sclerosis (MS), lesions of the optic nerve are not included as an anatomical substrate for dissemination in space and time (DIS and DIT).

Objective: To assess the increase in sensitivity of including MRI lesions of the optic nerve for the diagnosis of MS in patients with ON.

Methods: We included patients consecutively referred with first time, monosymptomatic ON, with no known cause of the ON, who underwent orbital MRI including fat suppressed T2 and T1-sequences with and without gadolinium contrast.

Results: One hundred and twenty patients were included. Optic nerve T2 lesions and/or T1-contrast enhancement was shown in 104 patients. Sixty-three patients were diagnosed with MS at baseline. Nine patients developed MS during follow-up. The inclusion of optic nerve MRI lesions led to the diagnosis of 8 additional patients and increased sensitivity to 0.99 (95% CI 0.96-1.00) compared to 0.88 (95% CI 0.79-0.95) for 2017 criteria, while decreasing the specificity to 0.81 (95% CI 0.70-0.92) compared to 1.00.

Conclusion: Amending the diagnostic criteria for MS to include MRI lesions of the optic nerve as a substrate for DIS and DIT may increase sensitivity and lead to more rapid diagnosis of MS.

References

Thompson A, Banwell B, Barkhof F, Carroll W, Coetzee T, Comi G . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017; 17(2):162-173. DOI: 10.1016/S1474-4422(17)30470-2. View

Polman C, Reingold S, Banwell B, Clanet M, Cohen J, Filippi M . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69(2):292-302. PMC: 3084507. DOI: 10.1002/ana.22366. View

Kupersmith M, Alban T, Zeiffer B, Lefton D . Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain. 2002; 125(Pt 4):812-22. DOI: 10.1093/brain/awf087. View

Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Di Pauli F . Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis. Neurology. 2023; 101(8):e784-e793. PMC: 10449446. DOI: 10.1212/WNL.0000000000207507. View

. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol. 2008; 65(6):727-32. PMC: 2440583. DOI: 10.1001/archneur.65.6.727. View

Tintore M, Rovira A, Rio J, Otero-Romero S, Arrambide G, Tur C . Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain. 2015; 138(Pt 7):1863-74. DOI: 10.1093/brain/awv105. View

Berg S, Kaschka I, Utz K, Huhn K, Lammer A, Lammer R . Baseline magnetic resonance imaging of the optic nerve provides limited predictive information on short-term recovery after acute optic neuritis. PLoS One. 2015; 10(1):e0113961. PMC: 4312052. DOI: 10.1371/journal.pone.0113961. View

Pihl-Jensen G, Ivanov I, Hinze D, Trauzettel-Klosinski S, Frederiksen J . Sensitive Assessment of Acute Optic Neuritis by a New, Digital Flicker Test. Ophthalmic Res. 2019; 63(3):332-340. DOI: 10.1159/000503304. View

Vidal-Jordana A, Rovira A, Arrambide G, Otero-Romero S, Rio J, Comabella M . Optic Nerve Topography in Multiple Sclerosis Diagnosis: The Utility of Visual Evoked Potentials. Neurology. 2020; 96(4):e482-e490. PMC: 7905792. DOI: 10.1212/WNL.0000000000011339. View

10.

Barton J, Garber J, Klistorner A, Barnett M . The electrophysiological assessment of visual function in Multiple Sclerosis. Clin Neurophysiol Pract. 2019; 4:90-96. PMC: 6539333. DOI: 10.1016/j.cnp.2019.03.002. View

11.

Tintore M, Rovira A, Rio J, Nos C, Grive E, Tellez N . Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology. 2006; 67(6):968-72. DOI: 10.1212/01.wnl.0000237354.10144.ec. View

12.

Nayar R, Schutten E, Jangalwe S, Durost P, Kenney L, Conley J . IRF4 Regulates the Ratio of T-Bet to Eomesodermin in CD8+ T Cells Responding to Persistent LCMV Infection. PLoS One. 2015; 10(12):e0144826. PMC: 4699851. DOI: 10.1371/journal.pone.0144826. View

12.

Costello F, Coupland S, Hodge W, Lorello G, Koroluk J, Pan Y . Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006; 59(6):963-9. DOI: 10.1002/ana.20851. View

13.

Vidal-Jordana A, Rovira A, Calderon W, Arrambide G, Castillo J, Moncho D . Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study. Neurology. 2024; 102(1):e200805. PMC: 10834130. DOI: 10.1212/WNL.0000000000207805. View

14.

Pihl-Jensen G, Wanscher B, Frederiksen J . Multifocal visual evoked potential evaluation for diagnosis of acute optic neuritis and for prediction of visual outcome and ganglion cell layer thinning following optic neuritis. Mult Scler. 2021; 27(11):1717-1726. DOI: 10.1177/1352458520975732. View

15.

Nolan-Kenney R, Liu M, Akhand O, Calabresi P, Paul F, Petzold A . Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study. Ann Neurol. 2019; 85(5):618-629. DOI: 10.1002/ana.25462. View

16.

Miller A . Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?. Mult Scler. 2024; 30(4-5):479-482. DOI: 10.1177/13524585241233999. View

17.

Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A . Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study. Lancet Neurol. 2017; 17(2):133-142. DOI: 10.1016/S1474-4422(17)30469-6. View

18.

Toosy A, Mason D, Miller D . Optic neuritis. Lancet Neurol. 2013; 13(1):83-99. DOI: 10.1016/S1474-4422(13)70259-X. View

19.

Mongay-Ochoa N, Pareto D, Alberich M, Carbonell-Mirabent P, Valsasina P, Margoni M . Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis. Neurology. 2024; 104(1):e210136. DOI: 10.1212/WNL.0000000000210136. View